Moderna (MRNA) net assets (shareholders' equity)

Net assets · fiscal 2025
$8.65B

Moderna (MRNA) had net assets of $8.65B at the end of fiscal 2025 (December 31, 2025). That is 20.6% lower than the $10.90B of fiscal 2024. Figures as of 18 Nov 2026, 19:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$8.65B
Change on fiscal 2024
−20.6%
Growth, 5 years
+27.6% a year
Highest on record
$19.12Bfiscal 2022
Lowest on record
-$551.37Mfiscal 2017
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Moderna net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 27.6% a year. Across the 10 fiscal years on record (2016–2025), the highest was $19.12B in fiscal 2022 and the lowest -$551.37M in fiscal 2017.

History · 10 fiscal years

Net assets by fiscal year

Moderna net assets (shareholders' equity), year by year

Moderna (MRNA) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$8.65B 20.6% down
2024$10.90B 21.3% down
2023$13.85B 27.6% down
2022$19.12B 35.2% up
2021$14.15B 452.3% up
2020$2.56B 118.0% up
2019$1.18B 23.2% down
2018$1.53B—
2017-$551.37M—
2016-$334.81M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Moderna and comparable companies
CompanyNet assetsFiscal year
McKesson MCK-$2.17B2026
Sanofi SNY€71.38B2025
Moderna MRNA$8.65B2025
CVS Health CVS$75.21B2025
HCA Healthcare HCA-$6.03B2025
GSK GSK£16.38B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MRNA

Moderna, figure by figure

Moderna (MRNA) overview: price, valuation and scorecardAll health care companies by market value

Moderna net assets (shareholders' equity): questions and answers

What are Moderna's net assets?

Moderna (MRNA) had net assets of $8.65B at the end of fiscal 2025 (December 31, 2025). That is 20.6% lower than the $10.90B of fiscal 2024.

What is the growth rate of Moderna's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 27.6% a year.

What are the highest and lowest net assets figures on record for Moderna?

Across the 10 fiscal years on record (2016–2025), the highest was $19.12B in fiscal 2022 and the lowest -$551.37M in fiscal 2017.

How is Moderna's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Moderna it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Moderna (MRNA) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/MRNA/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.